EIF4EBP1 and glioblastoma: The antibodies used were first tested in WB on five adult glioblastomas without alterations of the MAPK/TSC/mTOR pathway by NGS, and were confirmed to recognize a specific band at the expected size for both phosphorylated and total 4E-BP1 (Figure 4A).